相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

SMAD3,激素依赖乳腺癌中的细胞增殖和淋巴结转移

Mohamed Oueslati¹, Nadia Sassi², Ilhem Bettaieb³

¹Faculté des sciences de Bizerte.

La Tunisie medicale

|September 8, 2023

概括

瘤生长因子-β (TGF-β) 信号,特别是SMAD3,在激素受体阳性 (ER+,PR+) 瘤中促进乳腺癌细胞的增殖和转移. 这表明,对于侵袭性乳腺癌亚型来说,它是一个潜在的治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞信号传递细胞信号传递

背景情况:

瘤生长因子-β (TGF-β) 是一种关键的细胞因子,涉及各种病理,包括乳腺癌 (BC).
乳腺癌的进展受到激素受体 (如雌激素受体 (ERα,ERβ) 和孕激素受体 (PR)) 的显著影响.

研究的目的:

研究TGF-β信号通路组件与乳腺癌中的激素受体表达之间的潜在交叉对话.
阐明SMAD3的作用,这是TGF-β信号传递的关键媒介,与激素受体状态和瘤攻击性有关.

主要方法:

使用定量实时PCR (qRT-PCR) 来分析40个乳腺瘤组织样本中SMAD3,ERα,ERβ和PR的表达水平.
免疫组织化学被用来确定Ki-67 (增殖标志物) 和HER2/neu. 的状态.

主要成果:

发现乳腺瘤中SMAD3表达变化,过度表达与较高的瘤等级有关.
过度表达SMAD3与瘤细胞增多 (Ki-67) 和转移,包括淋巴结透,正相关.
在SMAD3表达和激素受体阳性子组 (ERα+,ERβ+和PR+) 之间观察到显著的关联.

结论:

在ERα+,ERβ+和PR+乳腺癌中,SMAD3在促进细胞增殖和转移方面发挥作用.
这些发现突出了TGF-β信号传递和激素受体通路之间的潜在联系,在驱动攻击性乳腺癌表型方面.

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...